pemoline has been researched along with Allergy, Drug in 1 studies
Pemoline: A central nervous system stimulant used in fatigue and depressive states and to treat hyperkinetic disorders in children.
pemoline : A member of the class of 1,3-oxazoles that is 1,3-oxazol-4(5H)-one which is substituted by an amino group at position 2 and by a phenyl group at position 5. A central nervous system stimulant, it was used to treat hyperactivity disorders in children, but withdrawn from use following reports of serious hepatotoxicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "It typically takes many years before an association of a drug with a rare, serious adverse reaction is established." | 1.37 | Safety assessment in pediatric studies. ( Elzagallaai, A; Etwel, F; Koren, G, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koren, G | 1 |
| Elzagallaai, A | 1 |
| Etwel, F | 1 |
1 other study available for pemoline and Allergy, Drug
| Article | Year |
|---|---|
Safety assessment in pediatric studies.
Topics: Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Canada; Cell Death; Drug Hypersensit | 2011 |